Showing results (21-30 of 208) with videos related to
Sort By:
Pageof 21
Cancer Research|April 3, 2003
Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamineBo Yang, Nino Keshelava, Clarke P Anderson, et al.Molecular Cancer Therapeutics|March 17, 2007
A fluorescence microplate cytotoxicity assay with a 4-log dynamic range that identifies synergistic drug combinationsTomas Frgala, Ondrej Kalous, Robert T Proffitt, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 21, 2004
Liquid chromatography method for quantifying N-(4-hydroxyphenyl)retinamide and N-(4-methoxyphenyl)retinamide in tissuesJitka Vratilova, Tomas Frgala, Barry J Maurer, et al.Current Drug Targets|June 23, 2007
Assessing combinations of cytotoxic agents using leukemia cell linesC Patrick Reynolds, Min H Kang, Nino Keshelava, et al.Methods in Molecular Medicine|May 20, 2005
DIMSCAN: a microcomputer fluorescence-based cytotoxicity assay for preclinical testing of combination chemotherapyNino Keshelava, Tomás Frgala, Jirí Krejsa, et al.Experimental Biology and Medicine (Maywood, N.J.)|April 22, 2017
Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectivesJason P Cooper, C Patrick Reynolds, Hwangeui Cho, et al.Pediatric Blood & Cancer|January 24, 2006
Collection, storage, and infusion of stem cells in children with high-risk neuroblastoma: saving for a rainy dayStephan A Grupp, Susan L Cohn, Donna Wall, et al.Experimental Biology and Medicine (Maywood, N.J.)|June 22, 2014
Caspase-dependent Mcl-1 cleavage and effect of Mcl-1 phosphorylation in ABT-737-induced apoptosis in human acute lymphoblastic leukemia cell linesYongKu Ryu, Connor P Hall, C Patrick Reynolds, et al.Cancer Letters|July 26, 2003
Retinoid therapy of high-risk neuroblastomaC Patrick Reynolds, Katherine K Matthay, Judith G Villablanca, et al.Journal of Clinical Medicine|October 14, 2023
A Multi-Color Flow Cytometric Assay for Quantifying Dinutuximab Binding to Neuroblastoma Cells in Tumor, Bone Marrow, and BloodMichelle E Keyel, Kathryn L Furr, Min H Kang, et al.Pageof 21